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Introduction
Monomeric postsynaptic snake α-neurotoxins, from the venom of elapid and hydrophiid snakes, produce rapid paralysis of skeletal muscle by a potent curaremimetic action to antagonise nicotinic acetylcholine receptors (nAChR). Snake α-neurotoxins and other animal toxins have therefore been fundamental tools for studying nAChR structure and function.
Indeed certain conopeptide nAChR antagonists from Conus spp. are currently in development as potential analgesic agents [1] .
All nAChRs are composed of five subunits, with muscle-type receptors consisting of four subunits: (α1) 2 βγδ in the developing muscle, and (α1) 2 βεδ in the mature human form [2] .
The most widely studied muscle-type nAChR, however, is the heteropentameric (α1) 2 βγδ receptor expressed in the electric organ from various species of Torpedo [3] . Much of the progress in nAChR research was originally connected to the accessibility of high quantities of this muscle-type nAChR. Nevertheless, it was the discovery, and subsequent use, of polypeptide elapid snake α-neurotoxins as potent and selective receptor ligands that made possible the purification of preparative amounts of Torpedo nAChR. Thus snake α-neurotoxins were, and remain, invaluable tools for the purification and more recently characterization of nAChR receptors. In addtion to their use as tools, such post-synaptic nAChRs inhibitors may also find use as therapeutic agents, in pathologies involving dysfunction of the neuromuscular junction.
The polypeptide backbone of all snake α-neurotoxins adopts the same overall tertiary fold. This comprises four conserved disulfide bridges, forming a hydrophobic core, and three adjacent loops (I, II and III) rich in β-pleated sheets; hence their alternate name 'threefingered' neurotoxins [4] . Snake α-neurotoxins are divided into two groups based on the length of their primary sequence: short-chain vs. long-chain α-neurotoxins. Short-chain α-neurotoxins typically comprise of 60-62 amino acids with four disulfide bonds, while longchain α-neurotoxins typically consist of 66-75 residues with an additional C-terminal tail segment, a slightly shorter first loop, and normally five disulfide bonds [4] . The additional fifth disulfide bond (Cys IV -Cys V ) in long-chain α-neurotoxins cyclizes a helix-like conformation at the tip of the middle loop (loop II) [4] . Despite these structural variations, snake α-neurotoxins from both groups bind to similar sites, and with comparable high affinity, on Torpedo or skeletal muscle nAChRs (Table 1) . Nevertheless, a major difference is that short-chain α-neurotoxins are known to associate 6-7-fold faster to, and dissociate 5-9-fold more rapidly from, skeletal muscle nAChRs than long-chain α-neurotoxins [5] . Indeed, the slowed dissociation rate can be the result of pseudo-irreversible binding [6] .
More recently it was found that long-chain α-neurotoxins, and the structurally related, but dimeric, κ-bungarotoxin (from Bungarus multicinctus), also antagonize neuronal nAChRs, 5 while short-chain α-neurotoxins that lack this fifth disulfide bridge bind to neuronal nAChRs with around 3-5 orders of magnitude lower affinity (see Table 1 ). In contrast to muscle-type (α1) 2 βγδ receptors, neuronal nAChRs consist of only one or two subunits: α (α2-α10) and β (β2-β4). They can be homopentameric (eg. neuronal α7-type or (α7) 5 ) or heteropentameric (eg. ganglionic α3β2-type or (α3) 2 (β2) 3 ) in configuration. Studies have revealed that longchain α-neurotoxins potently block neuronal homopentameric nAChRs, especially the α7-type [7] . Several lines of evidence have suggested that high affinity for the α7 nAChR is associated with the presence of the extra fifth disulfide (Cys IV -Cys V ) in loop II of long-chain α-neurotoxins. Firstly, selective reduction and carboxymethylation of the fifth disulfide of the long-chain α-cobratoxin resulted in a marked reduction in neuronal α7 nAChR binding affinity. Importantly however there was no significant change in the affinity of the alkylated toxin for the muscle (α1) 2 βγδ nAChR [7] . In parallel experiments, mutation of each of the halfcystines into serine in the fifth disulfide of α-cobratoxin or α-bungarotoxin, also resulted in loss of affinity for the α7 nAChR but maintained high affinity for (α1) 2 βγδ nAChRs [8] [9] [10] .
Secondly, the removal of the fifth disulfide bond Cys 27 -Cys 31 in the structurally related κ-bungarotoxin, selective for α3β2 neuronal nAChRs, also resulted in a significant loss of affinity despite maintenance of the β-sheet structure in this region [11] . Lastly, Lc long neurotoxin 1 from Laticauda colubrina, despite showing high sequence homology with other long-chain α-neurotoxins, lacks the fifth disulfide bond and lacks affinity for the α7 nAChR (Table 1 and [7] ). The above evidence clearly supports the hypothesis that the fifth disulfide is critical for neuronal nAChR affinity [7] [8] [9] [10] [11] . To further test this hypothesis Lyukmanova et al.
[ A large number of studies have identified a variety of snake α-neurotoxins subtypes from marine and Asian terrestrial elapids (Serpentes, Elapidae), however only more recently have toxins of Australo-Papuan terrestrial elapids begun to be characterized pharmacologically.
Amongst these snakes, the Australian common death adder (Acanthophis antarcticus) has a highly lethal venom, with an LD 50 in mice of 0.338 mg/kg [13] and an average venom yield of 79.1 mg, equivalent to more than 11,000 LD 50 doses in mice [14] . Despite its viper-like appearance, A. antarcticus venom lacks cytotoxins and myotoxins [15] [16] [17] but has recently been shown to express a presynaptic neurotoxin complex [18] , often associated with 6
Australian elapid venoms. Furthermore several short-chain [19, 20] and long-chain [21] [22] [23] the toxicity of all these toxins, except the long-chain α-neurotoxin acanthophin d [22] , is assumed based on size of toxin and symptoms arising from single parenteral administration in mice. As such there has been no thorough testing to determine the mode of action for these neurotoxins.
In the present study we describe the isolation and characterization of a novel long-chain postsynaptic α-neurotoxin from A. antarcticus (NSW) venom. We have named the novel toxin α-elapitoxin-Aa2a (α-EPTX-Aa2a) as recommended by the rational nomenclature system proposed for the naming of spider, Conus and other peptide toxins [24] . The activity descriptor prefix 'α' indicates an antagonist of nicotinic acetylcholine receptors, 'elapitoxin' is the generic name for toxins from the family Elapidae (see Table 3 in the Supplementary data within [24] ), 'Aa' is the genus and species descriptor for Acanthophis antarcticus, '2'
represents long-chain α-neurotoxins ('1' represents short-chain α-neurotoxins, '3' represents neuronal κ-neurotoxins), and 'a' denotes the first paralog (isoform) found.
We demonstrate using a variety of nerve-muscle organ bath functional assays and competition receptor binding assays that α-EPTX-Aa2a shows high affinity for muscle-type (α1) 2 βγδ nAChR. However, unlike other long-chain α-neurotoxins, α-EPTX-Aa2a has very weak activity on neuronal α7 nAChR, despite the presence of a fifth disulfide bond.
Materials and methods

Venom / toxin preparation and storage
Lyophilized A. antarcticus venom (New South Wales variant) was provided by the Australian Reptile Park (Gosford, NSW). Death adders were collected from their natural habitats in the Sydney metropolitan region. To minimise the effects of individual variations in venom [25] , venom was collected from several snakes, pooled and lyophilized by the supplier. Venom obtained from a single individual female snake (Bega, NSW) was also provided by the Australian Reptile Park. Venom and isolated toxins were stored lyophilized at -20 °C until required.
Venom fractionation
Bioassay-guided isolation of toxins from whole venom was performed using a Shimadzu CLASS-VP HPLC system. Prior to separation, samples were suspended in equilibration buffer and centrifuged at 10,000 rpm for 5 min (MiniSpin plus centrifuge; Eppendorf, North 7
Ryde, NSW, Australia), with the resulting supernatant applied to the HPLC system. Elution profiles were then monitored at 280 and 214 nm.
Size-exclusion FPLC
Whole venom was applied to a Superdex-75 FPLC column (10 x 300 mm, 13 µm; GE Healthcare, Sydney, NSW, Australia) previously equilibrated with ammonium acetate (0.1 M, pH 6.8). Fractions were then eluted using an isocratic gradient of ammonium acetate at a flow rate of 0.75 ml/min. Resulting fractions were screened for neurotoxic and myotoxic activity using the isolated chick biventer cervicis nerve-muscle (CBCNM) preparation (see section 2.5). The approximate molecular mass estimation for each eluted fraction was achieved by calibrating the size-exclusion FPLC column using a series of molecular weight markers, as previously described [26] .
Ion-exchange FPLC
Neurotoxic components, identified following isolation of whole venom using size-exclusion FPLC, were further purified using cation-exchange FPLC. Samples were applied to a TOSOH TSK-GEL SP-5PW cation-exchange column (7.5 x 75 mm, 10 µm; SUPELCO, Bellefonte, PA, USA) with fractions eluted using an ammonium acetate gradient (Buffer A: 
Electrospray-ionization quadrupole time-of-flight (ESI-QTOF) mass spectrometry
Once purity was confirmed, the definitive masses of RP-HPLC samples were determined using a QSTAR Elite hybrid QTOF mass spectrometer system (Applied Biosystems/MDS Sciex, Foster City, CA, USA) equipped with a nanospray source, as previously described [18] .
Isolated chick biventer cervicis nerve-muscle preparation
Isolated peptide fractions were tested for neurotoxic and myotoxic activity using the isolated CBCNM preparation [27] . Male Australorps chicks aged 1-7 days were anesthetized with Muscle tension was recorded using CHART v5.5.4 software (ADInstruments). Twitch tension and contractile responses to exogenous agonists were expressed as a percentage of the initial control twitch contraction amplitude prior to addition of toxin.
Antivenom reversibility studies
The efficacy of monovalent death adder antivenom (CSL Biotherapies, Melbourne, Australia)
to neutralise the activity of purified α-EPTX-Aa2a was assessed by preincubating the organ bath with 5 U/ml of antivenom for 10 min prior to addition of toxin. Reversibility studies were also performed by the addition of 5 U/ml monovalent death adder antivenom at 90%
inhibition of twitch contractions (t 90 ). Twitches were monitored for 5 hours after addition of α-EPTX-Aa2a or until stable twitch height was reached.
Carbachol concentration-response curves
Cumulative concentration-response curves to carbachol (CCh) were obtained in the unstimulated chick biventer cervicis nerve-muscle preparation. Concentration-response curves were constructed from successive additions of CCh without washout, at final bath concentrations of 0.8-1000 µM prior to, and following, a 1 hour incubation with toxin.
Successive doses of CCh were added only after stable muscle tension was achieved following the previous dose. If no immediate increase in muscle tension was visible, additional doses were added after a 3 minute waiting period.
Membrane preparation for radioligand binding assays
Receptor-enriched membranes were prepared according to a method adapted from Whiteaker et al. [28] . Eight female Sprague-Dawley (180-220 g) rats were gassed by CO 2 (80% in 20% O 2 ) and killed by decapitation. The brains were removed and placed on an icecold platform. The hippocampus from each brain was dissected and homogenized using a glass homogeniser in 50 volumes of ice-cold hypotonic homogenizing buffer of the following composition (in mM): NaCl, 14.4; KCl, 0.2; CaCl 2 , 0.2; MgSO 4 , 0.1; HEPES 2; pH 7.5.
Membrane fractions were collected by centrifugation at 25,000 g for 15 min at 4 °C. The pellets were then resuspended in fresh homogenization buffer, incubated on ice for 10 min then harvested by centrifugation as before. Each pellet was washed twice more by re-suspension / centrifugation before storage at -80 ºC until required. Protein content was then quantified using a BCA protein assay (see section 2.3).
125 I-α-Bungarotoxin binding assay
Competition binding studies using 125 I-α-bungarotoxin (Perkin Elmer, Waltham, MA, USA)
were adapted from Davies et al. [29] . Brain membrane pellets were resuspended to a concentration of 2 mg/ml in binding buffer of the following composition (in mM): NaCl, 144;
KCl , 
Secretory phospholipase A 2 (sPLA 2 ) activity assay
The sPLA 2 activity of whole venom and isolated toxins were determined using a colorimetric sPLA 2 assay kit (Cayman Chemical Ltd, Ann Arbor, MI, USA) as previously described [18] .
sPLA 2 activity was calculated as micromoles of substrate hydrolyzed per minute per milligram of enzyme (µmol/min/mg), using bee venom (Apis mellifera) as a positive control.
Partial N-terminal sequence determination
Partial N-terminal sequencing of purified proteins was performed by the Biomolecular
Research Facility at the University of Newcastle, NSW, Australia using an Applied Biosystems Procise HT Protein Sequencer. Samples were loaded onto a biobrene-treated, precycled disc and subjected to N-terminal (Edman) sequencing. Sequence homology of purified proteins with existing toxins was determined using a Blastp search of the UniProt Knowledgebase (http://ca.expasy.org/tools/blast) followed by a ClustalW multiple alignment.
Chemicals and drugs
Unless otherwise stated, all chemicals and drugs were purchased from Sigma-Aldrich, Castle
Hill, NSW, Australia. Unless otherwise indicated, all drugs were made up and diluted in distilled water.
Data analysis
Biventer 
where pEC 30 denotes the negative logarithm of the EC 30 , [B] denotes the antagonist concentration, pK and log c are fitting constants, and s is equivalent to the Schild slope factor [32] . When concentration-response curve spacings deviate from the predictions of a simple competitive interaction s is significantly different from unity and the pA 2 value can be estimated by pA 2 = pK / s. Deviation from competitive antagonism was also confirmed by comparing the goodness-of-fit of Eq. (2) with a simple Lew Angus equation (Eq. 3) using an extra sum-of-squares F test within the PRISM software package [33] .
where the pK B is given directly as a fitted parameter [30, 31] . 
Results
Venom fractionation
Isolation of toxins from snake venom sourced from an individual snake benefits from ease of purification, as a result of a reduction in the complexity of peptide/protein components.
However it may not be representative of all venoms from that species. Thus the presence of purified toxin from individual snake venom was also confirmed in the pooled venom sample. (note: minimum marker mass is 6.5 kDa) following calibration of the size-exclusion column with a series of molecular weight markers (Fig. 1C and D) . Peak absorbances of pooled and individual venom occurred at 19.6 and 19.1 min, respectively ( Fig. 1A and B ), corresponding to a molecular mass of ca. 8.7 kDa ( Fig. 2A) and ca. 10.3 kDa (Fig. 2B ). ƒ3 therefore is likely to contain Kunitz-type protease inhibitors (ca. 6400-6700 Da), short-chain α-neurotoxins (ca.
6700-7100 Da), long-chain α-neurotoxins (ca. 7200-8900 Da) and monomeric PLA 2 neurotoxins (ca. 12800-14000 Da).
Fraction 3 from both pooled and individual venoms was further separated using cation exchange FPLC (Fig. 1E and F , the toxin present in both these fractions was found to be identical and was named α-elapitoxin-Aa2a (α-EPTX-Aa2a).
Mass spectrometry
MALDI-TOF mass spectrometry confirmed the purity of ƒ3.11.2 (data not shown) and ƒ3.7.2 ( Fig. 2A) . ESI-QTOF mass spectrometry determined the definitive mass of ƒ3.11.2 (data not shown) and ƒ3.7.2 ( Fig. 2B) to both be 8850.0 Da, confirming their matching identity. This mass is consistent with long-chain snake α-neurotoxins although, to our knowledge it is the highest mass elapid snake α-neurotoxin so far described.
Neurotoxicity studies
Given that ƒ3.7.2 was less easily contaminated by closely eluting fractions, and more abundant, all subsequent biochemical and pharmacological characterization was performed with α-EPTX-Aa2a derived from individual venom (ƒ3.7.2). α-EPTX-Aa2a (0.1-1 µM)
produced a rapid concentration-dependent inhibition of nerve-evoked twitch contractions in the CBCNM preparation, while time-matched controls were not significantly inhibited ( Fig.   3Aa -Ab). The t 90 value of 1 µM α-EPTX-Aa2a for inhibition of twitch contractions was 15.5 ± 3.2 min (n = 4) that increased to 38.5 ± 6.6 min using 100 nM (n = 4; Fig. 3Ad ). Importantly, Furthermore, α-EPTX-Aa2a failed to induce any significant change in baseline tension (data not shown). These actions are consistent with the presence of a snake α-neurotoxin that inhibits postsynaptic nAChRs without any overt signs of myotoxicity.
Antivenom neutralization and reversibility studies
Preincubation with monovalent death adder antivenom (5 U/ml) was completely effective in preventing the development of neuromuscular blockade (Fig. 3Ac) , and inhibition of responses to cholinergic agonists ( Fig. 3Bb ; n = 4, one-way ANOVA, p > 0.05 vs. timematched controls), by 0.1 µM α-EPTX-Aa2a. However, attempts at reversing neuromuscular blockade by 0.1 µM α-EPTX-Aa2a using monovalent death antivenom (5 U/ml) applied at t 90 failed to reverse toxicity ( Fig. 4A-B ). Significant inhibition of contractures to ACh and CCh were also still observed after incubation with antivenom at t 90 ( Fig. 4C ; n = 4, one-way ANOVA, p < 0.001 vs. time-matched controls).
Secretory phospholipase A 2 (sPLA 2 ) activity
The sPLA 2 activity of whole venom and α-EPTX-Aa2a was 257 ± 14 µmol/min/mg and 0.4 ± 0.6 µmol/min/mg, respectively (n = 4, data not shown). In comparison, the sPLA 2 activity of the positive control, Apis mellifera bee venom, was 287 ± 10 µmol/min/mg (n = 18).
Effects on carbachol concentration-response curves
Cumulative CCh concentration-response curves in the CBCNM preparation in the absence, and presence, of α-EPTX-Aa2a resulted in a decrease in the maximal response to CCh, consistent with pseudo-irreversible binding to the muscle nAChR. Fig. 5B and C) .
Effects on neuronal nicotinic receptors (nAChRs)
In hippocampus homogenate, the positive control d-tubocurarine was a potent inhibitor of specific radioiodinated α-bungarotoxin binding to rat neuronal α7 nAChRs, however α-EPTX- values of 4.07 ± 2.99 µM and 214 ± 134 µM, respectively (n = 3; Fig. 5D ).
N-terminal sequence
A 35 residue partial N-terminal sequence was determined for α-EPTX-Aa2a by Edman degradation (Fig. 6) . The α-EPTX-Aa2a sequence was subjected to a Blastp analysis of the UniProt Knowledgebase and found to show high homology with a range of long-chain snake α-neurotoxins from A. antarcticus. To avoid the confusing ad hoc naming system for snake toxins we have elected to employ the recently proposed rational nomenclature system for peptide toxins [24] . Accordingly, the A. antarcticus toxins with high homology to α-EPTXAa2a were the paralogs α-EPTX-Aa2e (formerly Aa e [23] ; 8752 Da, 83% homology), α-EPTX-Aa2b (formerly Aa b [21] ; 8135 Da, 80% homology), and α-EPTX-Aa2d (formerly acanthophin d [22] ; 8387 Da, 80% homology), but not the short-chain α-neurotoxins α-EPTXAa1a (formerly acanthophin a, [20] ; ca. 7700 Da) and α-EPTX-Aa1c (formerly Aa c, [19] ; 6880 Da).
Discussion
Previous in vitro studies from our laboratories have shown that Australo-Papuan death adder (Acanthophis spp.) venoms are among the most neurotoxic elapid venoms [35, 36] . While we have recently characterized the presence of a presynaptic sPLA 2 
neurotoxin complex in
Acanthophis antarcticus venom [18, 26] , the slow development of neurotoxicity by presynaptic neurotoxins cannot explain the rapid neurotoxicity seen with whole venom [37] . It is commonly regarded that this rapid neurotoxicity is mainly postsynaptic in origin with five curaremimetic α-neurotoxins previously isolated. However, none of these toxins have been pharmacologically characterised, particularly their actions on nAChR subtypes.
In the present study, α-elapitoxin-Aa2a was isolated as a single peak by successive [38] . This may reflect the problem of ion suppression of protein mixtures using electrospray mass spectrometry methods.
The N-terminal sequence, mass and cysteine spacing of α-EPTX-Aa2a indicates that this toxin is a classical three-fingered neurotoxin, and has only limited sequence homology to non-conventional ('weak') snake toxins, such as irditoxin, denmotoxin and α-colubritoxin, and short-chain α-neurotoxins [4] . In particular, it lacks the extended loop I and the associated functionally important residues, characteristic of short-chain α-neurotoxins such as erabutoxin a. Furthermore, the fifth disulfide is not located in loop I (N-terminus loop), characteristic of 'weak' or non-conventional toxins (see Fig. 7 ).
Given the high sequence homology and mass consistent with other elapid postsynaptic neurotoxins, and the previous lack of pharmacological characterization of homologous toxins from A. antarcticus venom, α-EPTX-Aa2a was subjected to in vitro neurotoxicity testing using the CBCNM preparation. Initial in vitro testing confirmed the neurotoxic activity of α-EPTX- [43]). Along with the presynaptic sPLA 2 neurotoxin complex P-EPTX-Aa1a [18] and three other long-chain α-neurotoxins, α-EPTX-Aa2a may contribute to the difficulty in treating patients presenting late post-envenomation [45] . This may be the consequence of the high affinity for skeletal muscle nAChRs and slow dissociation as a result of pseudo-irreversible binding.
To investigate selectivity for other nAChR subtypes, the affinity of α-EPTX-Aa2a for homomeric α7 neuronal nAChR were studied in hippocampus homogenate, previously shown to be rich in this nAChR subtype [28] . Five other heteromeric nAChRs, containing various combinations of α3, α4, and/or α5 with β2 or β4 subunits, are also found in the hippocampus, however, snake neurotoxins lack affinity for these neuronal nAChR [46] . As expected the positive control, d-tubocurarine, was a potent inhibitor of 125 I-α-bungarotoxin binding to α7 nAChRs (K i 4.07 ± 2.99 µM). In contrast to other long-chain α-neurotoxins, however, α-EPTX-Aa2a displayed the lowest affinity for α7 nAChRs of any long-chain α-neurotoxin, so far tested, with a K i value of 214 ± 134 µM. This is about 165,000-fold less potent than α-bungarotoxin [43] , and around 53-fold less potent than d-tubocurarine. Thus despite its mass and sequence identity with long-chain α-neurotoxins, α-EPTX-Aa2a displays very high selectivity for muscle (α1) 2 βγδ nAChR in a similar fashion to short-chain α-neurotoxins, with whom it shares only limited sequence homology. Similar to short-chain neurotoxins, α-EPTX-Aa2a shows approximately 44,000-fold selectivity for muscle (α1) 2 βγδ vs. neuronal α7 receptors while long-chain α-neurotoxins have high affinity for α7 nAChR and only display 1-30-fold selectivity for muscle (α1) 2 βγδ nAChRs (see Table 1 ).
Other long-chain α-neurotoxins are missing the fifth disulfide bond and have shown to lack affinity for neuronal α7 receptors. For example, the 69-residue toxin Lc long neurotoxin 1
from Laticauda colubrina consists of 69 residues with Asp 30 and Gly 34 replacing the usual cysteine residues yet only has a K I of 7 µM for α7 nAChRs [7] (Table 1) . Nevertheless, the Nterminal sequence of α-EPTX-Aa2a confirms the presence of the Cys IV -Cys V residues, necessary for the formation of the fifth disulfide bond. Therefore, it is likely that the limited number of amino acid substitutions in loop II of α-EPTX-Aa2a may be responsible for the loss of affinity for α7 nAChRs.
Using site-directed mutagenesis, a number of residues have previously been identified to be functionally important and form the bioactive surface of short-chain α-neurotoxins (erabutoxin a) and long-chain α-neurotoxins (α-cobratoxin). These 'pharmacophore' residues that interact with Torpedo (α1) 2 'neuronal' pharmacophore residues that interact specifically with α7 AChRs [10, 47] . Thus, apart from Phe 65 in α-cobratoxin, all key residues important for neuronal α7 affinity in longchain α-neurotoxins are located in loop II, including the fifth disulphide.
α-EPTX-Aa2a is therefore atypical in that it represents the first long-chain α-neurotoxin that includes a fifth disulfide but lacks affinity for the α7 neuronal nAChR. Clearly, therefore, the fifth disulfide is not the sole requisite for neuronal activity and non-conservative substitutions of other residues in the vicinity of the fifth disulfide bond must be directly related to the capacity of long-chain α-neurotoxins to recognize the neuronal α7 receptor.
Importantly, in the neuronal pharmacophore region of loop II, there are only two nonconserved substitutions in α-EPTX-Aa2a. The mostly likely cause for the loss of affinity for the α7 receptor is the hydrophobic Leu 33 substitution for the basic Arg 33 , critical for both neuronal and muscle activity [7] . A similar hydrophobic isoleucine residue is usually present in short-chain α-neurotoxins (see Fig. 7 ). Interestingly, there is still very high affinity for muscle (α1) 2 βγδ nAChRs, despite substitution of the critical Arg 33 present in α-cobratoxin, characterization of these toxins remains incomplete, we would predict that these toxins would also lack affinity for neuronal α7 nAChR (see Fig. 6 ). Current work aims to confirm this hypothesis.
In conclusion, α-EPTX-Aa2a represents the first long-chain α-neurotoxin isolated from A.
antarcticus to be fully pharmacologically characterised, and reveals an unique atypical selectivity for muscle vs. neuronal nAChRs not previously reported for long-chain α-neurotoxins. α-EPTX-Aa2a together with Lc long neurotoxin 1 from Laticauda colubrina [7] that lacks the fifth disulfide, behave functionally as short-chain neurotoxins at α7 nAChRs, despite their classification as long-chain α-neurotoxins. Thus, functional classification of α-neurotoxins requires pharmacological characterization of toxins at both skeletal muscle and neuronal nAChRs, rather than assumption of nAChR subtype activity based on size and number of disulfide bonds. 'Organism' refers to the venom source. and erabutoxin a whose mutation affects affinity for neuronal α7 (α-cobratoxin) and muscletype (α1) 2 βγδ (α-cobratoxin and erabutoxin a) nAChRs are marked with shaded arrowheads.
Arrowheads identify residues whose mutation results in a decrease in affinity of between 5-29 and 9-fold (white), a 10-and 100-fold decrease (gray), or >100-fold (black), while the gray circle indicates a mutation inducing an increase in affinity. Table: please ignore This study [7, 43, 51 
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